|
Market Cap (17-May) $2,292,313,856 (333rd) |
Close (30-Jun) $1.14 |
Volume (30-Jun) 2,606,681 |
Shortsold (5-May) 72,824,861 (5.70%) (40th) |
|
52w High $3.37 |
52w Low $0.88 |
P/E 454.55 |
EPS -0.14 |
MSB released this announcement to the ASX on 24 November 2022, 16:45. The announcement is not marked as price sensitive, and is 51 page(s) in length and 626.04kb in size.
You can view all announcements from MSB and see how they appear on a price chart on the announcements page.
At the date of this announcement, MSB was 3.755% short sold according to ASIC data. It was ranked the 70th most shorted stock on the ASX. It is now ranked as the 40th most shorted stock on the ASX with 5.699% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from MSB | |
|---|---|
| Change of Director's Interest Notice | 13 June 2023, 8:56 |
| Mesoblast Director Appointed to Strategic Advisory Role | 5 June 2023, 9:41 |
| MSB Reports Q3 Financial Results and Operational Highlights | 26 May 2023, 8:32 |
| Amended Constitution | 24 November 2022, 16:45 |
| Results of Meeting | 23 November 2022, 16:07 |
| Chairman's Address to Shareholders | 23 November 2022, 10:54 |
| Long-Term Survival for Acute GvHD Treatment with Remestemcel | 23 November 2022, 8:54 |
You must be logged in to post a reply.
Mesoblast 